Alpha-2-macroglobulin (A2M) is a potential treatment for cartilage-related conditions such as osteoarthritis, rheumatoid arthritis, and degenerative disc disease. A2M injections can prevent further joint deterioration by removing damaging proteins and supporting collagen.